Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dymista proof-of-concept study in persistent asthma and allergic rhinitis
2015-001093-17Phase 4Terminated
- Sponsor
- University of Dundee
- Start
- Nov 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone propionate, azelastine in persistent asthma, allergic rhinitis (AR), sponsored by University of Dundee. Started Nov 2018; status: terminated.
02
Drugs
fluticasone propionateazelastine
03
Conditions
persistent asthmaallergic rhinitis (AR)
Beyond the preview
Go deeper on 2015-001093-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001093-17.